Clinical Trial Update: A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer

View source ↗

Summary

This clinical trial update describes an ongoing multicenter prospective cohort study assessing adjuvant therapy for BRCA1/2-mutated, hormone receptor-positive, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast | Status: ENROLLING_BY_INVITATION